Skip to content
Nonprofiteer
← All organizations

HOPE FOR PDCD FOUNDATION

EIN 92-0361943 FOLSOM, CA

Browse the largest nonprofits in California

Revenue 2024
$330,431
Expenses 2024
$178,391

Program services were 99.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
03
NTEE code
H20
Classification
1000
Street
1106 BUCKBRUSH DR

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2024

Mission

Support and fund the development of life-saving treatment for patients with pyruvate dehydrogenase complex deficiency and related genetic diseases The activities of the foundation include providing grant funding to hospitals and medical research facilities which are conducting medical research for understanding and treatment of this condition The foundation also provides funding to individuals that assist with early patient identification through newborn screening for this condition.

Activities or mission (Part I)

Support and fund the development of life-saving treatment for patients with pyruvate dehydrogenase complex deficiency and related genetic diseases.

  • The foundation makes annual grants to tax exempt medical research facilities which conduct research in a variety of fields related to PDCD which will further the foundations mission of expanding the understanding and treatment of this condition This was a payment for University of Texas Southwestern UTSW Medical Facility as part of OTD Contract SRA202302-0021 to conduct gene therapy research for PDHA1 genetic mutations causing Pyruvate Dehydrogenase Complex Deficiency including but not limited to synthesis of vector design and development of a mouse colony and AAV vector manufacture

    Expenses $172,385 · Grants $172,385

  • Childrens Hospital of Philadelphia Activity Assay focuses on optimizing the detection of acetyl-CoA which is crucial for PDCD within the mass spectrometry instruments sensitivity range. The study compares media versus cells with reduced interference. Various PDCD lines mild vs. severe will be examined and contrasted. Additionally PDCD will be compared with other tricarboxylic cycle deficiencies and ETC defects to ensure distinguishability.

    Expenses $5,000 · Grants $5,000

As filed on the 2024 return.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • Frances Pimentel

    Chief Executive Officer

    Total calculated
    $0
    Hours/week
    10

  • Jon Pimentel

    Chief Financial Officer

    Total calculated
    $0
    Hours/week
    5

  • Kimberlee Muenzer

    Secretary

    Total calculated
    $0
    Hours/week
    1

  • Kim Higbee

    Director

    Total calculated
    $0
    Hours/week
    1

  • Katy Cairo

    Director

    Total calculated
    $0
    Hours/week
    1

  • Patricia Medlen

    Director

    Total calculated
    $0
    Hours/week
    1

  • Carly Tasiopoulos

    Director

    Total calculated
    $0
    Hours/week
    1

  • Chris Tasiopoulos

    Director

    Total calculated
    $0
    Hours/week
    1

  • Nikki Kulovitz

    Director

    Total calculated
    $0
    Hours/week
    1

  • Molly Naccarato

    Director

    Total calculated
    $0
    Hours/week
    1

  • Brandy Jackson

    Director

    Total calculated
    $0
    Hours/week
    1

  • Layna O'Connor

    Director

    Total calculated
    $0
    Hours/week
    1

  • Natasha Baril

    Director

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. Earlier years are each on their own filing page.

Filings

  • 2024
    Revenue
    $330,431
    Expenses
    $178,391
    Contributions
    $329,977
    Grants paid
    $177,385
  • 2023
    Revenue
    $426,280
    Expenses
    $175,725
    Contributions
    $426,808
    Grants paid
    $174,884
  • 2022
    Revenue
    $208,000
    Expenses
    $52,702
    Contributions
    $208,000
    Grants paid
    $50,000

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Grants made

Where these grants went next →

Grants received

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Listed as of 13 October 2026, under deductibility PC.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.

What this page reflects

The registration facts above come from the IRS Business Master File published 13 October 2026 and read 1 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.